Hims Hers Health Inc
For the period ended Dec 31, 2024. Filed Feb 24, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 24, 2025
HIMS$22.94-11.8%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statement of Stockholders’ Equity
Consolidated Statements of Stockholders' Equity
(In Thousands, Except Share Data)
| Common Stock · AdditionalPaid-InCapital · AccumulatedOtherComprehensiveLoss · AccumulatedDeficit · TotalStockholders' Equity | ||||||
|---|---|---|---|---|---|---|
| Shares · Amount | ||||||
| Balance as of December 31, 2021 | 204,791,986 | $20 | $613,687 | $(137) | $(278,951) | $334,619 |
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes | 1,632,111 | — | — | — | — | — |
| Payments for taxes related to net share settlement of equity awards | — | — | (3,901) | — | — | (3,901) |
| Exercise of vested stock options | 1,611,687 | 1 | 2,245 | — | — | 2,246 |
| Vesting of early exercised stock options | — | — | 197 | — | — | 197 |
| Issuance of common stock under employee stock purchase plan | 393,528 | — | 1,178 | — | — | 1,178 |
| Stock-based compensation | — | — | 43,220 | — | — | 43,220 |
| Other comprehensive loss | — | — | — | (140) | — | (140) |
| Net loss | — | — | — | — | (65,678) | (65,678) |
| Balance as of December 31, 2022 | 208,429,312 | 21 | 656,626 | (277) | (344,629) | 311,741 |
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes | 3,472,456 | — | — | — | — | — |
| Payments for taxes related to net share settlement of equity awards | — | — | (14,096) | — | — | (14,096) |
| Exercise of vested stock options | 1,222,548 | — | 2,322 | — | — | 2,322 |
| Issuance of common stock under employee stock purchase plan | 594,885 | — | 2,298 | — | — | 2,298 |
| Repurchases and retirement of common stock | (237,458) | — | (1,999) | — | — | (1,999) |
| Stock-based compensation | — | — | 67,156 | — | — | 67,156 |
| Other comprehensive income | — | — | — | 153 | — | 153 |
| Net loss | — | — | — | — | (23,546) | (23,546) |
| Balance as of December 31, 2023 | 213,481,743 | 21 | 712,307 | (124) | (368,175) | 344,029 |
| Issuance of common stock upon vesting of RSUs, net of shares withheld for taxes | 4,404,420 | — | — | — | — | — |
| Payments for taxes related to net share settlement of equity awards | — | — | (52,501) | — | — | (52,501) |
| Exercise of vested stock options | 6,734,549 | 1 | 26,650 | — | — | 26,651 |
| Exercise of Class A common stock warrants | 271,291 | — | 333 | — | — | 333 |
| Repurchases and retirement of common stock | (5,768,042) | — | (83,039) | — | — | (83,039) |
| Issuance of common stock under employee stock purchase plan | 617,563 | — | 3,901 | — | — | 3,901 |
| Issuance of common stock for acquisition-related earn-out consideration | 119,344 | — | 1,396 | — | — | 1,396 |
| Issuance of common stock for acquisition of business | 976,341 | — | 15,500 | — | — | 15,500 |
| Stock-based compensation | — | — | 94,608 | — | — | 94,608 |
| Other comprehensive loss | — | — | — | (200) | — | (200) |
| Net income | — | — | — | — | 126,038 | 126,038 |
| Balance as of December 31, 2024 | 220,837,209 | $22 | $719,155 | $(324) | $(242,137) | $476,716 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.